PDB33 - DAPAGLIFLOZIN: COST EFFECTIVENESS AS AN ADD-ON THERAPY TO METFORMIN IN THE TREATMENT OF TYPE 2 DIABETES IN ECUADOR
Elgart, J.F. ; Prestes, M. ; Gonzalez, L. ; Solis Sanchez, C. ; Acosta, W. ; Solorzano, J. ; Gagliardino, J.J.
Value in health, 2016-05, Vol.19 (3), p.A202-A202 [Periódico revisado por pares]Elsevier Inc
Texto completo disponível